Items where authors include "Drummond, M.F."

Export as [feed] Atom [feed] RSS
Number of items: 28.

Article

Reckers-Droog, Vivian., Federici, Carlo., Brouwer, Werner. et al. (1 more author) (2020) Challenges with Coverage with Evidence Development Schemes for Medical Devices : A Systematic Review. Health Policy and Technology. pp. 146-156. ISSN 2211-8845

Drummond, M.F. orcid.org/0000-0002-6126-0944, Torbica, A. and Tarricone, R. (2020) Should Health Technology Assessment be more patient-centric? If so, how? European Journal of Health Economics. ISSN 1618-7601

Meregaglia, M., Whittal, A., Nicod, E. et al. (1 more author) (2020) ‘Mapping’ health state utility values from non-preference-based measures : a systematic literature review in rare diseases. Pharmacoeconomics. ISSN 1179-2027

Drummond, M.F. orcid.org/0000-0002-6126-0944 (2019) Modeling in Early Stages of Technology Development: Is an iterative approach needed? : Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”. International Journal of Health Policy and Management. ISSN 2322-5939

Drummond, M.F. orcid.org/0000-0002-6126-0944, Neumann, P., Sullivan, S. et al. (4 more authors) (2019) Analytic considerations in applying a general economic evaluation reference case to gene therapy. Value in Health. pp. 661-668. ISSN 1524-4733

Justo, N., Espinoza, M., Ratto, B. et al. (7 more authors) (2019) Real-World Evidence in Healthcare Decision Making : Global trends and case studies from Latin America. Value in Health. pp. 739-749. ISSN 1524-4733

Kanavos, P., Angelis, A. and Drummond, M.F. orcid.org/0000-0002-6126-0944 (2019) An EU-wide approach to HTA : an irrelevant development or an opportunity not to be missed? European Journal of Health Economics. pp. 329-332. ISSN 1618-7601

Kristensen, F. B., Husereau, D., Huic, M. et al. (14 more authors) (2019) Identifying the need for good practices in Health Technology Assessment : summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Value in Health. pp. 13-20. ISSN 1524-4733

Torbica, A., Tarricone, Rosanna and Drummond, M.F. orcid.org/0000-0002-6126-0944 (2018) Does the approach to economic evaluation in health care depend on culture, values, and institutional context? European Journal of Health Economics. pp. 769-774. ISSN 1618-7601

Phelps, C., Lakdawalla, D., Basu, A. et al. (3 more authors) (2018) Approaches to Aggregation and Decision Making - A Health Economics Approach : An ISPOR Special Task Force Report [5]. Value in Health. 146 - 154. ISSN 1524-4733

Garrison, Louis R., Neumann, P., Willke, R. et al. (10 more authors) (2018) A Health Economics Approach to US Value Assessment Frameworks - Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value in Health. pp. 161-165. ISSN 1524-4733

Danzon, P., Drummond, M.F. orcid.org/0000-0002-6126-0944, Towse, A. et al. (1 more author) (2018) Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]. Value in Health. 140 - 145. ISSN 1524-4733

Ciani, O., Buyse, M., Drummond, M.F. orcid.org/0000-0002-6126-0944 et al. (3 more authors) (2017) Time to review the role of surrogate endpoints in health policy: state of the art and the way forward. Value in Health. pp. 487-495. ISSN 1524-4733

Tarricone, R., Torbica, A., Drummond, M.F. orcid.org/0000-0002-6126-0944 et al. (1 more author) (2017) Foreword: : guest editors, Supplement 1, 2017, of Health Economics. Health Economics. pp. 3-4. ISSN 1057-9230

Tarricone, R., Torbica, A. and Drummond, M.F. orcid.org/0000-0002-6126-0944 (2017) Challenges in the assessment of medical devices: the MedtecHTA project. Health Economics. pp. 5-12. ISSN 1057-9230

Becker, D., Chit, A., DiazGranados, C. et al. (3 more authors) (2016) High-Dose Inactivated Influenza Vaccine is Associated with Cost Savings and Better Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors. Human Vaccines & Immunotherapeutics. pp. 3036-3042. ISSN 2164-5515

Rencz, F., Gulacsi, L., Drummond, M.F. orcid.org/0000-0002-6126-0944 et al. (10 more authors) (2016) EQ-5D in Central and Eastern Europe : 2000-2015. Quality of life research. pp. 2693-2710. ISSN 1573-2649

Drummond, M.F. orcid.org/0000-0002-6126-0944, Tarricone, R. and Torbica, A. (2016) Incentivizing research into the effectiveness of medical devices. European Journal of Health Economics. pp. 1055-1058. ISSN 1618-7601

Ciani, O., Buyse, M., Drummond, M.F. orcid.org/0000-0002-6126-0944 et al. (3 more authors) (2016) Use of surrogate endpoints in healthcare policy : proposal for consistent adoption of a validation framework. Nature Reviews Drug Discovery. pp. 1-2. ISSN 1474-1784

Drummond, M.F. orcid.org/0000-0002-6126-0944, Augustovski, F., Kalo, Z. et al. (4 more authors) (2015) Challenges faced in transferring economic evaluations to middle income countries. International Journal of Technology Assessment in Health Care. pp. 1-7. ISSN 0266-4623

Pichon-Riviere, A., Garay, O.U., Augustovski, F. et al. (7 more authors) (2015) Implications of global pricing policies on access to innovative drugs: : the case of trastuzumab in seven Latin American countries. International Journal of Technology Assessment in Health Care. pp. 2-11. ISSN 0266-4623

Aballea, S., Chancellor, J.V.M., Raikou, M. et al. (4 more authors) (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer, 109 (6). pp. 1082-1089. ISSN 0008-543X

Drummond, M.F., Barbieri, M. and Wong, J.B. (2005) Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference? Medical Decision Making, 25 (5). pp. 520-533. ISSN 0272-989X

Mason, A.R., Drummond, M.F., Hunter, J.A. et al. (2 more authors) (2005) Prescribing incentive schemes : a useful approach? Applied Health Economics and Health Policy, 4 (2). pp. 111-117. ISSN 1175-5652

Taylor, R.S., Drummond, M.F., Salkeld, G. et al. (1 more author) (2004) Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ, 329 (7472). pp. 972-975. ISSN 0959-8146

Drummond, M.F., Becker, D.L., Hux, M. et al. (4 more authors) (2003) An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. Chest, 124 (2). pp. 526-535. ISSN 0012-3692

Mason, J.M., Drummond, M.F. orcid.org/0000-0002-6126-0944, Bosanquet, A.G. et al. (1 more author) (1999) The DiSC assay - A cost-effective guide to treatment for chronic lymphocytic leukemia? International Journal of Technology Assessment in Health Care. pp. 173-184. ISSN 0266-4623

Book Section

Drummond, M.F. orcid.org/0000-0002-6126-0944, Tarricone, Rosanna and Torbica, A. (2018) Economic Evaluation of Medical Devices. In: Hamilton, J.H., (ed.) Oxford Research Encyclopedia of Economics and Finance. Oxford University Press , Oxford .

This list was generated on Sat Apr 20 13:56:04 2024 BST.